Henri Vanni has been a member of the Denzler & Partners Board of Directors since 2009.
Since his retirement from McKinsey & Company in 2007, Mr. Vanni has been an independent consultant supporting leaders of industrial, pharmaceutical, and biotechnology companies on core strategic challenges. He is currently a member of several boards of directors, in industries from healthcare to private banking, including Novartis, Lombard Odier SA, and the life sciences incubator, Eclosion.
Mr. Vanni holds an engineering degree in Chemistry from the Swiss Federal Institute of Technology (EPFL) of Lausanne, Switzerland, a PhD in Chemistry from the University of Lausanne, and a Master of Business Administration from INSEAD in Fontainebleau, France.
He began his career as a research engineer at IBM Corp. in California, United States, and joined McKinsey & Company in Zurich in 1980. He founded and managed the Geneva office for McKinsey from 1988 to 2004, and advised companies in the pharmaceutical, consumer, and finance sectors. He led McKinsey’s European Life Sciences practice and served as member of the partner review committee of the firm prior to his retirement in 2007.